Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy For Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria.

64 246 182 64 130 194 •Chemotherapy-induced febrile neutropenia (FN) is a well-known complication associated with increased morbidity and mortality and frequently leads to additional hospitalization 1-3; •Severe and prolonged neutropenia is associated with fever and infections that require systemic therapy (antibiotics, antimicotics etc); •Prophylactic use of G-CSFs in high risk patients (≥ 20% FN risk) can greatly reduce neutropenic complications of CT4; •To date, no studies have been conducted in Bulgaria, exploring the HCRU for patients suffering from chemotherapy-induced FN in clinical practice.